A pilot study to estimate the Pediatric radiation dose during thyroid, renal, and bone scan

Abstract

Pediatric patients benefited from nuclear medicine (NM) results. NM provides information regarding the general and localized function of the body's organs, systems, and lesions. This includes applications in the bone, neuro, renal, cardiovascular, endocrine, and other organ systems, as well as in detecting and managing cancer. The administration of radiopharmaceuticals associated with exposure to ionizing radiation is a necessary component of NM practice. This study aims to estimate the Pediatric radiation dose during thyroid, renal, and bone scans. Methods The study involved 161 pediatric patients who underwent thyroid, renal, and bone scans using Tc-99m radionuclide. Effective dose has been estimated using web-based software depending on conductive activity.Effective dose has been estimated using computer software depending on conductive activity. The results show patient dose information from thyroid, renal, and bone scans. For a thyroid scan, the patient's age was 12.26 ± 3.65 years, the patient's height was 1.43 ± 0.20 cm, and the patient's weight was 41.87 ± 16.56 kg. The activity was 2.89 ± 1.12 mCi, and the effective dose for thyroid was 1.92 ± 0.81 mSv. For the renal scan, the patient's age was 6.55 ± 4.83 years, height was 1.09 ± 0.37 cm, and weight was 24.01 ± 18.19 kg. The activity was 2.41 ± 0.88 mCi, and the effective dose was 0.72 ± 0.19 mSv. for a bone scan patient's age was 11 ± 4.12 years, the patient's height was 1.4 ± 0.19 cm, the patient's 33.64 ± 14.3 kg. the activity 11.46 ± 3.64 mCi and the effective dose 3.1 ± 0.61 mSv.Implementing national guidelines must improve the practice and patient safety, and the relationship between administered activity and patient weight needs to be better understood.